<DOC>
	<DOC>NCT01367899</DOC>
	<brief_summary>The objective of this post-approval study is to provide scientifically valid and reliable evidence that supports claims of longer term safety and effectiveness with regard to Month 120 device survivorship rates.</brief_summary>
	<brief_title>CONSERVE Plus Post-Approval Study (PAS)</brief_title>
	<detailed_description>This study will evaluate the performance of CONSERVE Plus Hip Resurfacing System under actual conditions of use. Additionally, this study will evaluate the performance of the device in the post approval environment to see if there are any significant changes in device performance as compared to the pre-market IDE Study</detailed_description>
	<criteria>1. Was previously enrolled in the CONSERVEÂ® Plus IDE as part of the All Enrolled Audited Cohort (N=1366 procedures (1206 patients)) and received the "Original Shell". 2. Is willing and able to comply with the study plan and able to understand and sign the Patient Informed Consent Form. 1. Patient is mentally incompetent. 2. Patient is a prisoner. 3. Patient is an alcohol and/or drug abuser 4. Patient has undergone device revision or removal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
</DOC>